When is targeted therapy recommended for thyroid cancer?

Targeted medicines act on particular signals or changes that help cancer cells grow. The choice depends on the thyroid cancer type, where it is located, how quickly it is changing, symptoms, earlier treatments, and your general health. Some thyroid cancers can be managed with surgery, radioactive iodine, thyroid hormone treatment, or monitoring, so targeted therapy is not automatically needed after diagnosis.

Your team may review scans, blood tests, pathology, and sometimes molecular testing of tumour tissue. These results can show whether a medicine is a reasonable match and whether its possible benefits outweigh effects such as tiredness, skin changes, diarrhoea, blood-pressure changes, or liver problems.

Ask which treatment goal applies to you: slowing growth, reducing symptoms, shrinking disease, or making another treatment possible. Bring a list of medicines and supplements, including doses, because interactions can matter. Tell the team about heart, liver, kidney, and blood-pressure problems, previous operations, and any plans for pregnancy.

Before treatment, ask how the medicine is taken, which checks are needed, how side effects will be managed, and what would lead to a dose change or pause. You can read more about [Targeted Therapy](/treatments/systemic-therapy/targeted-therapy/) and [Thyroid Cancer](/conditions/thyroid-cancer/).

Contact your oncology team promptly for new or worsening neck swelling, trouble breathing or swallowing, severe diarrhoea, persistent vomiting, unusual bleeding, marked weakness, chest pain, or a severe rash. Sudden breathlessness, fainting, confusion, or signs of a serious allergic reaction need urgent emergency care.

What feature of my thyroid cancer makes targeted therapy worth considering? Do I need molecular testing? What alternatives are available? Which side effects should I report the same day, and how will scans and blood tests show whether treatment is helping?